This compound is a pharmaceutical intermediate used in the synthesis of statins. It contains a complex aromatic and heterocyclic structure with multiple functional groups, consistent with its role as a building block in the manufacture of cholesterol-lowering medications.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 93957-52-9
Fluvastatin methyl ester
pharmaceutical intermediate for statin synthesis
(R,E)-Methyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate
Pharmaceutical intermediate for statin synthesis
3-Pyridin-3-yl-D-alanine--hydrogen chloride (1/2)
pharmaceutical intermediate
3-BROMO-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
Pharmaceutical intermediate
Ethyl 4-(butylamino)benzoate
Pharmaceutical intermediate
5-Chlorobenzotriazole
peptide coupling reagent intermediate
1,1-Dimethylethyl (6E)-7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-5-hydroxy-3-oxo-6-heptenoate
statin HMG-CoA reductase inhibitor
FLUVASTATIN SODIUM
active pharmaceutical ingredient
methyl (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3-hydroxy-5-oxohept-6-enoate
KYRVMHRSMHMKAP-OUKQBFOZSA-N
CC(C)N1C2=CC=CC=C2C(=C1/C=C/C(=O)CC(CC(=O)OC)O)C3=CC=C(C=C3)F